Meeting to be held March 27 hosted by Oppenheimer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBP:
- Corbus Pharmaceuticals files $300M mixed securities shelf
- Corbus Pharmaceuticals price target raised to $58 from $51 at Oppenheimer
- Corbus Pharmaceuticals Shares Informal Financial Snapshot
- Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
- Corbus Pharmaceuticals sees cash runway through March 31, 2027